logo
logo

Actylis completes acquisition of Pharm-Rx to enhance its portfolio and capabilities

Oct 07, 2024•10 months ago

Acquiring Company

Actylis

Acquired Company

Pharm Rx Chemical Corp

Port WashingtonSaddle BrookBiotechnologyManufacturingFood and BeverageBiotechnologyManufacturing

Description

Actylis, a provider of differentiated specialty ingredients, has strategically acquired Pharm-Rx, a leading value-added supplier of specialty ingredients for the vitamin, mineral, and supplement (“VMS”) and pharmaceutical industries. This acquisition significantly enhances Actylis’ ability to deliver exceptional value to its customers, increases its range of solutions for clients, and strengthens its strategic supplier partnerships to enhance its innovative portfolio and service offerings.

Company Information

Company

Actylis

Location

Port Washington, New York, United States

About

Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and Agriscience industries. We offer standard and custom ingredients through our rapidly growing portfolio of GMP and non-GMP facilities worldwide, and further choice through our strong sourcing hub network. This unique hybrid option blending manufacturing and global sourcing, combined with more than 75 years of sourcing and distribution experience makes Actylis the Partner of Choice.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Nicholas hidden

hidden

Valentina hidden

hidden

Shivangi hidden

hidden